Cologuard is a solid screening tool for colorectal cancer, catching about 92% of cancers in clinical trials, but it’s notably less reliable at finding precancerous growths. The newer version, Cologuard Plus, bumps cancer detection up to 95.3%. Either way, it’s not as thorough as a colonoscopy, which remains the gold standard. But for people who want a non-invasive option they can do at home, Cologuard offers meaningful protection.
How Well It Detects Cancer
In a large clinical trial of nearly 10,000 patients called DeeP-C, the original Cologuard detected 92% of colorectal cancers with 87% specificity. That means it catches the vast majority of actual cancers, and when it comes back negative, you can be 99.94% confident you don’t have cancer. The false negative rate sits around 8%, meaning roughly 1 in 12 cancers goes undetected.
Cologuard Plus, cleared by the FDA more recently, performs better. It detects 95.3% of colorectal cancers with 90.7% specificity. In head-to-head testing, Cologuard Plus caught 21 of 25 cancers that a standard stool blood test (FIT) missed entirely. FIT, by comparison, only detected about 71% of cancers. The collection process for both versions of Cologuard is identical, so there’s no added complexity with the upgraded test.
Where It Falls Short: Precancerous Polyps
This is Cologuard’s biggest weakness. The whole point of colon cancer screening is ideally to find and remove growths before they become cancer. Cologuard detects advanced precancerous polyps only about 42% of the time. That means it misses more than half of these growths.
Detection varies considerably based on the size and location of the polyp. Larger polyps (30 mm or bigger) are caught about 68% of the time, while small ones under 5 mm are detected only 20% of the time. Polyps located in the part of the colon closer to the rectum (distal) are caught at 55%, while those farther up (proximal) are found just 33% of the time. High-grade precancerous lesions, which are closer to becoming cancer, are detected at a higher rate of 69%.
Cologuard Plus improves precancerous detection modestly, finding 43.3% of advanced precancerous lesions compared to FIT’s 23.3%. It’s better than a simple stool blood test, but still far behind what a colonoscopy can find, since a gastroenterologist visually inspects the entire colon and removes polyps on the spot.
False Positives and What They Mean for You
Cologuard has a false positive rate of about 13% with the original version, improving to roughly 9% with Cologuard Plus. That means about 1 in 8 to 1 in 11 people will get a positive result even though nothing concerning is actually there. A positive Cologuard result always requires a follow-up colonoscopy to determine what’s going on, so a false positive means you’ll end up getting the procedure you were trying to avoid.
This matters for cost, too. If your follow-up colonoscopy is classified as “diagnostic” rather than “screening,” private insurers may charge you the usual deductible and co-pay. Medicare is more generous here: it covers the follow-up colonoscopy after a positive stool test without the typical cost-sharing, though you might owe 15% of the approved amount if a polyp is found and removed during the procedure.
Who Should and Shouldn’t Use It
Cologuard is designed for average-risk adults. The U.S. Preventive Services Task Force recommends starting colorectal cancer screening at age 45, and stool DNA tests like Cologuard are one of several accepted options. The recommended interval is every one to three years.
You’re not a candidate for Cologuard if you have a personal history of colorectal cancer or advanced precancerous polyps, a first-degree relative (parent, sibling, or child) diagnosed with colorectal cancer at any age, inflammatory bowel disease such as Crohn’s or ulcerative colitis, or a hereditary cancer syndrome like Lynch syndrome or familial adenomatous polyposis. People with these risk factors need colonoscopy on a schedule their doctor determines.
How the Test Works in Practice
Cologuard arrives as a kit shipped to your home. You collect a stool sample, which the test analyzes for altered DNA shed by cancerous or precancerous cells, along with traces of blood. There’s no special diet or bowel preparation required, which is the main appeal over colonoscopy.
Timing matters once you’ve collected your sample. You need to ship the box within 24 hours using the prepaid label, and the sample must reach the lab within 72 hours. Store the kit at room temperature and keep it away from direct sunlight and heat before shipping. Results typically come back within a couple of weeks.
Cologuard vs. Colonoscopy
Colonoscopy remains the most thorough option. It detects over 95% of cancers and the vast majority of precancerous polyps, and any polyps found can be removed immediately during the same procedure. You only need it every 10 years if results are normal. The trade-off is sedation, bowel prep, a day off work, and a small risk of complications like perforation.
Cologuard’s advantage is convenience and zero physical risk. You do it at home with no prep, no sedation, and no time off. But because it misses more than half of precancerous polyps and needs to be repeated every one to three years, you’re relying on repeated testing to catch things a single colonoscopy would find. Over a decade of screening, missing a polyp on one round could be caught on the next, but there’s no guarantee.
For people who would otherwise skip screening entirely, Cologuard is far better than nothing. Colorectal cancer found early through screening has a five-year survival rate above 90%, compared to below 15% when found at a late stage. The best screening test is the one you’ll actually complete, and Cologuard removes enough barriers that many people follow through when they wouldn’t schedule a colonoscopy.